Welcome to subscribe to press releases and news from Peptonic Medical.
Enter your e-mail address in the form and and we will send regular news straight to your inbox.
All published press releases from PEPTONIC medical is available on spotlightstockmarket.com.
PEPTONIC Medical is an innovative Swedish pharmaceutical company developing and commercializing safe and effective products for the treatment of menopausal symptoms, such as vaginal atrophy. VagiVital® is a registered trademark of PEPTONIC Medical. The product is being commercialised for the non-prescription use for the treatment of vaginal atrophy.
The Company was founded in 2009 and its first candidate drug product is Vagitocin® – an estrogen-free oxytocin based product for the treatment of vaginal atrophy in clinical development phase 2.
Oxytocin has a long history of safe and effective medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women.
Det är viktigt för oss att du ska känna dig trygg med hur vi hanterar dina personuppgifter. Läs mer om detta på vår sida Dataskyddspolicy: